Search results
Systemic lupus erythematosus (SLE) is a chronic systemic autoimmune disease of variable severity and course, characterised by a tendency for flare (figure 1).1 In SLE, both innate and adaptive immune responses are involved.
This review summarizes current evidence regarding the diagnosis, treatment, and prognosis of systemic lupus erythematosus.
1 sty 2021 · Article PDF Available. A Review of Systemic Lupus Erythematosus (SLE): Symptoms, Risk Factors, Treatment, and Health Related Quality of Life Issues. January 2021. Open Journal of...
Conclusions: The dimensions of self-concept and body image are essential for assessing the quality of life of individuals with lupus. The formation of a adjusted selfconcept can be managed by health professionals supporting these people.
7 maj 2024 · Systemic lupus erythematosus is associated with immune-mediated damage to multiple organs and increased mortality. Hydroxychloroquine is first-line therapy and reduces disease activity, morbidity, and mortality.
management of systemic lupus erythematosus (SLE), several studies have been published providing data on alternative therapeutic options and treatment targets. A systematic literature review (SLR) focusing on recent advances was performed to inform the 2023 update of EULAR recommendations for the management of SLE. WHAT THIS STUDY ADDS
Published by BMJ. ABSTRACT. Objectiveupus erythematosus (LE) is a complicated L disease with highly heterogeneous clinical manifestations. Previous studies have rarely included all subgroups of patients with lupus and have overlooked the importance of the cutaneous manifestations thereof.
